blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2994157

EP2994157 - TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.05.2021
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  29.05.2020
FormerGrant of patent is intended
Status updated on  15.12.2019
FormerExamination is in progress
Status updated on  12.05.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Université d'Aix-Marseille
Jardin du Pharo
58 Boulevard Charles Livon
13007 Marseille / FR
[2016/11]
Inventor(s)01 / MOQRICH, Aziz
74 rue Henri Tomasi
Le Mistral
F-13009 Marseille / FR
02 / DELFINI, Marie-Claire
Parc Scientifique de Luminy
F-13009 Marseille / FR
03 / MANTILLERI, Annabelle
31 Rue Estienne d'Orves
F-84400 Apt / FR
 [2016/11]
Representative(s)Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
[2016/11]
Application number, filing date14723045.206.05.2014
[2016/11]
WO2014EP59247
Priority number, dateEP2013030559206.05.2013         Original published format: EP 13305592
[2016/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014180853
Date:13.11.2014
Language:EN
[2014/46]
Type: A1 Application with search report 
No.:EP2994157
Date:16.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 13.11.2014 takes the place of the publication of the European patent application.
[2016/11]
Type: B1 Patent specification 
No.:EP2994157
Date:01.07.2020
Language:EN
[2020/27]
Search report(s)International search report - published on:EP13.11.2014
ClassificationIPC:A61K38/17
[2016/11]
CPC:
A61K38/195 (EP); A61K38/1709 (US); A01K67/0276 (US);
A61P23/00 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P43/00 (EP); C07K14/47 (US); A01K2217/077 (US);
A01K2227/105 (US); A01K2267/0356 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/11]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:TAFA4-VERBINDUNGEN UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON SCHMERZEN[2016/11]
English:TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN[2016/11]
French:COMPOSÉS TAFA4 ET LEURS UTILISATIONS POUR LE TRAITEMENT DE LA DOULEUR[2016/11]
Entry into regional phase30.11.2015National basic fee paid 
30.11.2015Designation fee(s) paid 
30.11.2015Examination fee paid 
Examination procedure30.11.2015Examination requested  [2016/11]
29.06.2016Amendment by applicant (claims and/or description)
16.05.2017Despatch of a communication from the examining division (Time limit: M06)
14.11.2017Reply to a communication from the examining division
15.10.2018Despatch of a communication from the examining division (Time limit: M06)
05.04.2019Reply to a communication from the examining division
16.12.2019Communication of intention to grant the patent
08.04.2020Fee for grant paid
08.04.2020Fee for publishing/printing paid
08.04.2020Receipt of the translation of the claim(s)
Opposition(s)06.04.2021No opposition filed within time limit [2021/23]
Fees paidRenewal fee
20.05.2016Renewal fee patent year 03
23.05.2017Renewal fee patent year 04
25.05.2018Renewal fee patent year 05
23.05.2019Renewal fee patent year 06
22.05.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.05.2014
AL01.07.2020
AT01.07.2020
CY01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
MC01.07.2020
MK01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SI01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
[2024/22]
Former [2023/30]HU06.05.2014
AL01.07.2020
AT01.07.2020
CY01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
MC01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SI01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2023/27]HU06.05.2014
AL01.07.2020
AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
MC01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SI01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2022/07]AL01.07.2020
AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
MC01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SI01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/36]AL01.07.2020
AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SI01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/28]AL01.07.2020
AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SK01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/25]AL01.07.2020
AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/22]AT01.07.2020
CZ01.07.2020
EE01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
PL01.07.2020
RO01.07.2020
RS01.07.2020
SM01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/11]AT01.07.2020
CZ01.07.2020
HR01.07.2020
LT01.07.2020
LV01.07.2020
PL01.07.2020
RS01.07.2020
BG01.10.2020
GR02.10.2020
IS01.11.2020
PT02.11.2020
Former [2021/09]AT01.07.2020
CZ01.07.2020
LT01.07.2020
BG01.10.2020
GR02.10.2020
PT02.11.2020
Former [2021/07]LT01.07.2020
BG01.10.2020
Former [2021/01]BG01.10.2020
Cited inInternational search[X]WO2006013462  (NSGENE AS [DK], et al);
 [X]US2009077680  (ABUIN ALEJANDRO [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.